首页 | 本学科首页   官方微博 | 高级检索  
     

直肠腺癌75例新辅助放化疗肿瘤退缩分级相关临床病理因素分析
引用本文:赵稳,李智,杜记涛,赵卫杰,陈广龙,曹建,万相斌. 直肠腺癌75例新辅助放化疗肿瘤退缩分级相关临床病理因素分析[J]. 中华肿瘤防治杂志, 2021, 28(1): 73-78
作者姓名:赵稳  李智  杜记涛  赵卫杰  陈广龙  曹建  万相斌
作者单位:郑州大学附属肿瘤医院普外科,河南 郑州 450008;郑州大学附属肿瘤医院普外科,河南 郑州 450008;郑州大学附属肿瘤医院普外科,河南 郑州 450008;郑州大学附属肿瘤医院普外科,河南 郑州 450008;郑州大学附属肿瘤医院普外科,河南 郑州 450008;郑州大学附属肿瘤医院普外科,河南 郑州 450008;郑州大学附属肿瘤医院普外科,河南 郑州 450008
基金项目:河南省科技攻关项目(162102310317)。
摘    要:目的 通过评估直肠腺癌患者对新辅助放化疗的反应率,旨在探讨新辅助放化疗后组织学消退的预测因素.方法 回顾性分析2015-06-01-2018-05-31郑州大学附属肿瘤医院接受新辅助放化疗,并行手术治疗的75例局部进展期直肠腺癌患者的临床病理资料,KRAS、NRAS和BRAF基因通过等位基因特异性PCR或Sanger测...

关 键 词:直肠腺癌  新辅助治疗  肿瘤退缩分级  预测因素

Analysis of clinicopathological factors related to tumor regression grade of neoadjuvant chemoradiotherapy in 75 cases for rectal adenocarcinoma
ZHAO Wen,LI Zhi,DU Ji-tao,ZHAO Wei-jie,CHEN Guang-long,CAO Jian,WAN Xiang-bin. Analysis of clinicopathological factors related to tumor regression grade of neoadjuvant chemoradiotherapy in 75 cases for rectal adenocarcinoma[J]. Chinese Journal of Cancer Prevention and Treatment, 2021, 28(1): 73-78
Authors:ZHAO Wen  LI Zhi  DU Ji-tao  ZHAO Wei-jie  CHEN Guang-long  CAO Jian  WAN Xiang-bin
Affiliation:(Department of General Surgery,Affiliated Cancer Hospital of Zhengzhou University&He'nan Cancer Hospital,Zhengzhou 450008,China)
Abstract:Objective To investigate the predictive factors of histological regression after preoperative chemoradiotherapy(PCRT)by evaluating the response rate of rectal adenocarcinoma patients to PCRT.Methods The clinicopathological date of 75 patients with locally advanced rectal adenocarcinoma who were treated by neoadjuvant chemoradiotherapy and surgery in the Affiliated Cancer Hospital of Zhengzhou University from June 1,2015 to May 31,2018 were retrospectively analyzed.The KRAS/NRAS/BRAFgene mutation was detected by using fluorescence-based allele-specific polymerase chain reaction or Sanger sequencing,and multiplex fluorescence PCR method was used to detect microsatellite instability of tumor tissue genes.Tumor regression grade(TRG)was used to evaluate the effect of peroperative chemoradiotherapy.Single factor and logistic multivariate regression analysis was performed.The relationships between clinicopathological&biological indicators and the sensitivity of PCRT were analyzed.Results Tumor regression grade:TRG0 in 14 cases(18.7%),TRG1 in 20 cases(26.6%),TRG2 in 33 cases(44.0%),TRG3 in 8 cases(10.7%).The incidence of patients with good tumor regression(TRG0+1)was 45.3%(34/75),and with no obvious tumor regression(TRG2+3)was54.7%(41/75).The mutation rates of KRASand BRAFgenes were 37.3%(28/75)and 4.0%(3/75)respectively.The detection rate of microsatellite instability-high(MSI-H)was 6.7%(5/75).According to univariate analysis,clinical T stage(χ2=5.291,P=0.021)&clinical N stage(χ2=4.546,P=0.033),tumor circumferential(χ2=6.482,P=0.011),nerve invasion or vascular tumor thrombus(χ2=5.105,P=0.024),tumor size(t=2.704,P=0.009)and KRASgene type(χ2=5.066,P=0.024)were a predictor of TRG grading level after PCRT for rectal adenocarcinoma.Multivariate logistic regression analysis manifested that tumor circumferential(OR=4.213,95%CI:1.223-14.515,P=0.023)and nerve invasion or vascular tumor thrombus(OR=4.544,95%CI:1.010-20.444,P=0.049)were independent predictors of TRG grade for rectal adenocarcinoma after PCRT.Conclusion Tumor circumferential and nerve invasion or vascular tumor thrombus are independent predictors of TRG grade for rectal adenocarcinoma after PCRT.
Keywords:rectal adenocarcinoma  neoadjuvant chemoradiotherapy  tumor regression grade  predictive factors
本文献已被 维普 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号